SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 14, 2003
HALSEY DRUG CO., INC.
695 North Perryville Road, Rockford, Illinois 61107
(815-399-2060)
Incorporated under the Commission File Number I.R.S. Employer
laws of State of New York 1-10113 Identification Number
11-0853640
Item 12. Results of Operations and Financial Condition
On August 14, 2003, Halsey Drug Co., Inc. (the "Company") issued a press
release disclosing the financial results for its second quarter ended June 30,
2003 and the six months ended June 30, 2003. A copy of the Company's press
release is attached as Exhibit 99.1 hereto.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(b) Exhibits
Exhibit
Number Description
------ -----------
99.1 Press Release dated August 14, 2003 Announcing Results for
Second Quarter ended June 30, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HALSEY DRUG CO., INC.
By: /s/ Peter A. Clemens
---------------------------
Peter A. Clemens
Vice President & Chief Financial Officer
Date: August 15, 2003
3
EXHIBIT INDEX
-------------
Exhibit
Number Description
------ -----------
99.1 Press Release dated August 14, 2003 Announcing
Results for Second Quarter ended June 30, 2003.
4